A Study in Healthy Volunteers to Assess Safety and Blood Levels of AZD9742 After Multiple Doses Over 14 Days



Status:Archived
Conditions:Healthy Studies
Therapuetic Areas:Other
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:February 2010
End Date:August 2010

Use our guide to learn which trials are right for you!

A Phase I, Single Center, Double-blind Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Intravenous AZD9742 After Administration of Multiple Ascending Doses for 14 Days in Healthy Male and Female Subjects


The purpose of this study is to determine the safety, tolerability and blood levels of
AZD9742 after daily dosing for 14 days.



We found this trial at
1
site
?
mi
from
Kansas City, KS
Click here to add this to my saved trials